vs
AMPCO PITTSBURGH CORP（AP）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是AMPCO PITTSBURGH CORP的2.0倍（$207.3M vs $104.4M），AMPCO PITTSBURGH CORP净利率更高（-55.2% vs -62.0%，领先6.8%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 11.5%），AMPCO PITTSBURGH CORP自由现金流更多（$-64.0K vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -2.6%）
安普科匹兹堡公司是一家特种钢材制造商，总部位于宾夕法尼亚州匹兹堡市中心，1929年由多家此前已成立的小型钢铁企业合并组建而成。需要注意区分它和其他同样带有Ampco名称的企业，比如位于密尔沃基的铜基合金生产商、迈阿密的橱柜企业等。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
AP vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $104.4M | $207.3M |
| 净利润 | $-57.7M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | -54.0% | -54.7% |
| 净利率 | -55.2% | -62.0% |
| 营收同比 | 11.5% | 25.9% |
| 净利润同比 | -1958.9% | 3.5% |
| 每股收益（稀释后） | $-2.87 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $104.4M | $207.3M | ||
| Q3 25 | $103.7M | $159.9M | ||
| Q2 25 | $108.9M | $166.5M | ||
| Q1 25 | $99.2M | $139.3M | ||
| Q4 24 | $93.6M | $164.6M | ||
| Q3 24 | $92.1M | $139.5M | ||
| Q2 24 | $107.1M | $147.0M | ||
| Q1 24 | $110.0M | $108.8M |
| Q4 25 | $-57.7M | $-128.6M | ||
| Q3 25 | $-2.2M | $-180.4M | ||
| Q2 25 | $-7.3M | $-115.0M | ||
| Q1 25 | $1.1M | $-151.1M | ||
| Q4 24 | $3.1M | $-133.2M | ||
| Q3 24 | $-2.0M | $-133.5M | ||
| Q2 24 | $2.0M | $-131.6M | ||
| Q1 24 | $-2.7M | $-170.7M |
| Q4 25 | -54.0% | -54.7% | ||
| Q3 25 | 1.1% | -106.9% | ||
| Q2 25 | -2.8% | -64.8% | ||
| Q1 25 | 3.9% | -102.6% | ||
| Q4 24 | 5.5% | -74.3% | ||
| Q3 24 | 2.0% | -94.6% | ||
| Q2 24 | 4.7% | -79.1% | ||
| Q1 24 | 0.1% | -151.9% |
| Q4 25 | -55.2% | -62.0% | ||
| Q3 25 | -2.1% | -112.8% | ||
| Q2 25 | -6.7% | -69.0% | ||
| Q1 25 | 1.2% | -108.5% | ||
| Q4 24 | 3.3% | -80.9% | ||
| Q3 24 | -2.1% | -95.7% | ||
| Q2 24 | 1.9% | -89.5% | ||
| Q1 24 | -2.5% | -156.8% |
| Q4 25 | $-2.87 | $-1.28 | ||
| Q3 25 | $-0.11 | $-1.81 | ||
| Q2 25 | $-0.36 | $-1.17 | ||
| Q1 25 | $0.06 | $-1.57 | ||
| Q4 24 | $0.16 | $-1.34 | ||
| Q3 24 | $-0.10 | $-1.40 | ||
| Q2 24 | $0.10 | $-1.52 | ||
| Q1 24 | $-0.14 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $10.7M | $421.0M |
| 总债务越低越好 | $117.9M | — |
| 股东权益账面价值 | $32.6M | $-80.0M |
| 总资产 | $495.4M | $1.5B |
| 负债/权益比越低杠杆越低 | 3.61× | — |
8季度趋势，按日历期对齐
| Q4 25 | $10.7M | $421.0M | ||
| Q3 25 | $15.0M | $202.5M | ||
| Q2 25 | $9.9M | $176.3M | ||
| Q1 25 | $7.1M | $127.1M | ||
| Q4 24 | $15.4M | $174.0M | ||
| Q3 24 | $11.8M | $150.6M | ||
| Q2 24 | $7.9M | $480.7M | ||
| Q1 24 | $10.8M | $112.3M |
| Q4 25 | $117.9M | — | ||
| Q3 25 | $119.0M | — | ||
| Q2 25 | $115.9M | — | ||
| Q1 25 | $115.0M | — | ||
| Q4 24 | $116.4M | — | ||
| Q3 24 | $116.0M | — | ||
| Q2 24 | $119.4M | — | ||
| Q1 24 | $116.2M | — |
| Q4 25 | $32.6M | $-80.0M | ||
| Q3 25 | $60.1M | $9.2M | ||
| Q2 25 | $62.7M | $151.3M | ||
| Q1 25 | $64.6M | $144.2M | ||
| Q4 24 | $58.9M | $255.0M | ||
| Q3 24 | $61.3M | $346.8M | ||
| Q2 24 | $58.0M | $432.4M | ||
| Q1 24 | $56.3M | $140.3M |
| Q4 25 | $495.4M | $1.5B | ||
| Q3 25 | $524.4M | $1.2B | ||
| Q2 25 | $537.2M | $1.3B | ||
| Q1 25 | $536.2M | $1.3B | ||
| Q4 24 | $530.9M | $1.5B | ||
| Q3 24 | $547.4M | $1.5B | ||
| Q2 24 | $560.8M | $1.6B | ||
| Q1 24 | $565.8M | $1.3B |
| Q4 25 | 3.61× | — | ||
| Q3 25 | 1.98× | — | ||
| Q2 25 | 1.85× | — | ||
| Q1 25 | 1.78× | — | ||
| Q4 24 | 1.98× | — | ||
| Q3 24 | 1.89× | — | ||
| Q2 24 | 2.06× | — | ||
| Q1 24 | 2.06× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.7M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-64.0K | $-100.8M |
| 自由现金流率自由现金流/营收 | -0.1% | -48.6% |
| 资本支出强度资本支出/营收 | 2.7% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.1M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $2.7M | $-99.8M | ||
| Q3 25 | $6.3M | $-91.4M | ||
| Q2 25 | $-2.3M | $-108.3M | ||
| Q1 25 | $-5.3M | $-166.5M | ||
| Q4 24 | $7.5M | $-79.3M | ||
| Q3 24 | $11.4M | $-67.0M | ||
| Q2 24 | $-5.3M | $-77.0M | ||
| Q1 24 | $4.5M | $-190.7M |
| Q4 25 | $-64.0K | $-100.8M | ||
| Q3 25 | $3.3M | $-92.7M | ||
| Q2 25 | $-3.8M | $-110.7M | ||
| Q1 25 | $-7.5M | $-167.8M | ||
| Q4 24 | $3.7M | $-79.5M | ||
| Q3 24 | $8.4M | $-68.6M | ||
| Q2 24 | $-8.0M | $-79.0M | ||
| Q1 24 | $1.7M | $-193.9M |
| Q4 25 | -0.1% | -48.6% | ||
| Q3 25 | 3.2% | -58.0% | ||
| Q2 25 | -3.5% | -66.5% | ||
| Q1 25 | -7.5% | -120.5% | ||
| Q4 24 | 4.0% | -48.3% | ||
| Q3 24 | 9.1% | -49.2% | ||
| Q2 24 | -7.5% | -53.7% | ||
| Q1 24 | 1.5% | -178.2% |
| Q4 25 | 2.7% | 0.5% | ||
| Q3 25 | 2.9% | 0.8% | ||
| Q2 25 | 1.3% | 1.5% | ||
| Q1 25 | 2.2% | 1.0% | ||
| Q4 24 | 4.0% | 0.1% | ||
| Q3 24 | 3.2% | 1.2% | ||
| Q2 24 | 2.5% | 1.4% | ||
| Q1 24 | 2.6% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -4.62× | — | ||
| Q4 24 | 2.40× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -2.64× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AP
| Forged And Cast Mill Rolls | $67.0M | 64% |
| Air Handling Systems | $14.3M | 14% |
| Heat Exchange Coils | $13.1M | 13% |
| Centrifugal Pumps | $10.3M | 10% |
| Forged Engineered Products | $4.0M | 4% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
